Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 7 results found. Search for [ Serum Institute's Covishield ]

Results 1 to 7 of 7
BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


Rajeev Dubey & Manoj Sharma
September 9, 2020
\"AstraZeneca has paused the trials due to some unrelated issue with a patient in the UK, and we'll have to wait for AstraZeneca to explain what happened but this is not vaccine-related,\" says Poonawalla


BusinessToday.In
August 23, 2020
Initially, the ICMR vaccine portal will disseminate information on coronavirus vaccine in India. However, with time, data available for all the vaccines will be added to the portal


BusinessToday.In
August 22, 2020
Bharat Biotech has received nod to conduct the Phase I and II clinical trial of its COVID-19 vaccine 'Covaxin' through intradermal route, which is just under the skin


PB Jayakumar
August 22, 2020
Centre has sought 68 crore doses for 130 crore Indian citizens from Serum Institute by June, next year


BusinessToday.In
July 30, 2020
Coronavirus vaccine news update: Serum Institute of India has been asked by Drug Controller General of India (DCGI) to change its protocol for Phase 2 and 3 trials of Oxford University-AstraZeneca COVID-19 vaccine


BusinessToday.In
July 29, 2020
The subject expert committee for COVID-19 related proposals under Central Drugs Standards Control Organisation (CDDSCO) asked Serum Institute to submit revised protocol for evaluation


PAGES 1 OF 1